Clinical Trials Browser

Phase 3 × PF06821497 × 30 days × Clear all

NCT07028853 2026-05-28

MEVPRO-3

Phase 3 Recruiting

Prostatic Neoplasms

NCT06629779 2026-05-20

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Phase 3 Recruiting

Metastatic Castration-Resistant Prostate Cancer

NCT06551324 2026-05-05

MEVPRO-1

Phase 3 Active not recruiting

Prostatic Neoplasms, Recurrence